PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0225DA003VITROS reagents — Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch holds $2.4M across 8 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

W40m Mrco Pacific
Awarding office
Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch
Recipient
—
Estimated value
6550
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberW81K0225DA003
AgencyW40m Mrco Pacific
Awarding officeW40m Mrco Pacific
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOrtho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch
UEIJNSJRDQQH2J6
PSC6550
Related solicitationW81K0225QA007

VITROS REAGENTS is a federal Unrestricted award for W40m Mrco Pacific held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Estimated value —. Related solicitation W81K0225QA007.

Bonuses end Sept 30

Want the durability read on W81K0225DA003? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch — $2.4M obligated across 8 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$2.4M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
W81K0225FA115
VITROS XT7600 REAGENTS FOR 51ST MDG, OSAN KOREA
$233K
Sep 30, 2026
W81K0223P0026
REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BRAIN D. ALLGOOD ARMY COMMUNITY HOS…
$2.0M
Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81K0225DA003?

W81K0225DA003 (VITROS reagents) is a W40m Mrco Pacific award with an estimated value of —, currently held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W81K0225DA003?

W40m Mrco Pacific awarded W81K0225DA003 to Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch.

Who is the incumbent on W81K0225DA003?

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch is the incumbent with $2.4M across 8 related awards in SCOUT’s public footprint.

When does Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch’s W81K0225DA003 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on W81K0225DA003? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81K0225DA003